CN103301216B - Ant cervical spondylosis recovering oil liniment and preparation method thereof - Google Patents
Ant cervical spondylosis recovering oil liniment and preparation method thereof Download PDFInfo
- Publication number
- CN103301216B CN103301216B CN201310258851.1A CN201310258851A CN103301216B CN 103301216 B CN103301216 B CN 103301216B CN 201310258851 A CN201310258851 A CN 201310258851A CN 103301216 B CN103301216 B CN 103301216B
- Authority
- CN
- China
- Prior art keywords
- oil
- grams
- cervical spondylosis
- preparation
- ant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940040145 liniment Drugs 0.000 title claims abstract description 16
- 239000000865 liniment Substances 0.000 title claims abstract description 16
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims abstract description 13
- 208000036319 cervical spondylosis Diseases 0.000 title claims abstract description 13
- 208000005801 spondylosis Diseases 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000003921 oil Substances 0.000 claims abstract description 85
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 9
- 241000903946 Clematidis Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241001251068 Formica fusca Species 0.000 claims description 21
- 241001660172 Polyrhachis Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 210000003205 muscle Anatomy 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000036407 pain Effects 0.000 abstract description 6
- 210000002435 tendon Anatomy 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000002040 relaxant effect Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 239000000341 volatile oil Substances 0.000 abstract description 3
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 241000802381 Polyrhachis vicina Species 0.000 abstract 1
- 241001620634 Roger Species 0.000 abstract 1
- 241000779819 Syncarpia glomulifera Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 241000830536 Tripterygium wilfordii Species 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000037368 penetrate the skin Effects 0.000 abstract 1
- 239000001739 pinus spp. Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 235000015398 thunder god vine Nutrition 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 229940036248 turpentine Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- DBPRUZCKPFOVDV-UHFFFAOYSA-N Clorprenaline hydrochloride Chemical class O.Cl.CC(C)NCC(O)C1=CC=CC=C1Cl DBPRUZCKPFOVDV-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000086550 Dinosauria Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- -1 has quality better Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides an ant cervical spondylosis recovering oil liniment and a preparation method thereof. The preparation method is characterized in that polyrhachis vicina roger essential oil is adopted and used as the main raw material, and lycopodium clavatum oil, cassia twig oil, angelica dahurica extract, caulis spatholobi oil, garden balsam stem oil, radix clematidis oil, tripterygium wilfordii oil and turpentine are adopted and compatible with the main raw material; the main raw material and the compatible materials are added to 95% medical methanol carrier and mixing uniformity. The ant cervical spondylosis recovering oil liniment has the effects of sedating, relieving uneasiness of mind and body tranquilization, resisting inflammation, reliving the tired muscle, relaxing tendons and activating collaterals, expelling wind and removing cold, clearing damp and swelling, and disinfecting and easing pain, can quickly penetrate the skin tissue of a human body, prompt the partial blood circulation, directly take part in the metabolic activity of the body, and enhance or improve a plurality of systems of the body, and achieves a remarkable effect on treating cervical spondylosis.
Description
Technical field
The present invention relates to a kind of Formica fusca JINGFUKANG oil externally-applied liniment for the treatment of cervical spondylosis, formed by active component and carrier, specifically taking ant essential oil as primary raw material, be aided with other Chinese herbal medicine quintessence oil and be prepared from according to a certain weight ratio.
Background technology
1, Formica fusca is ancient insecticide, and its ancestors can trace back to the Age of Dinosaur before more than 100,000,000 year.One of nature three great society insecticides.Before more than 100000000 year, the existence of existing Formica fusca on the earth, is the hugest and the most prosperous family of biological world.Formica fusca is a kind of rare medicinal herbs, records: Formica fusca place has it in Ming Dynasty's Li Shizhen (1518-1593 A.D.) Compendium of Material Medica one ... its Luan Ming Qi, recluse dig it, ancients eat it, therefore the bean that interior heavenly officials present food has fish or meat paste also: ordinary person eats it, the QI invigorating pool face person of dying food and heal also.The polyrhachis that is described as " natural medicine processing factory " has been listed in universally acknowledged edible medicinal, and for the United Nations names green health care food, within 1993, is become new resource food by Ministry of Public Health official approval.A kind of senior natural nourishing product.Modern medicine clinical trial certificate: the pharmacological action such as Formica fusca has antiinflammatory, analgesia, calmness, spasmolytic, it is late at night to protect, relieving asthma, convulsion..
2, percutaneous dosing can be traced back to the first two century in Christian era, is one of ancient administering mode.Percutaneous dosing is not only used for the treatment of local disease, is also used for the treatment of general disease.As just there being the description (local action) with " pig cream " treatment carbuncle skin ulcer in Huangdi's Internal Classics; The record (general action) of useful in " 52 Bingfang " " thunder arrow " (being Omphalia) dipping treatment " the sick epilepsy of baby ".
3, along with scientific and technical progress, multidisciplinary interpenetrate to the basis of lixiviate principle and process further investigation on, lixiviate new method, new technique, as semi-bionic extraction, ultrasonic extraction, supercritical fluid extraction, eddy flow extraction method, pressurized counter-flow extraction method, Enzymatic Extraction etc. are constantly used, improve the quality of Chinese medicine preparation.The production method of supercritical CO ↓ ［ 2 ］ extraction ant oil, has quality better, and lead tolerance is low, has retained the trace element such as a certain amount of zinc, manganese, has retained the natural aromatic composition of Formica fusca and the biological activity of Formica fusca class volatile ingredient.
Formica fusca is many for clinical treatment as a kind of medicine, has health care and also common report for the treatment of function; But Formica fusca oral medication disease has certain side effect unavoidably, and liniment can direct drug injection in affected part to people without any side effect.Liniment treated is not subject to place and time restriction, is more suitable for the current fast pace life of people; This compound method is simple, the easy to operate novelty that has more.
Summary of the invention
The object of the invention is to improve the formula of existing ant preparation, provide a kind of taking ant essential oil raw material as main, be aided with multiple Chinese herbal medicine quintessence oil and make the liniment that adaptation all kinds patient can gladly accept, put voluntarily wiping on the skin by patient, the mode of percutaneous dosing reaches the object for the treatment of and health.
A kind of Formica fusca JINGFUKANG oil externally-applied liniment for the treatment of cervical spondylosis of the present invention, is made up of active component and carrier.Active ingredient compositions is formed by following preferred Chinese crude drug quintessence oil proportioning: 50 grams of polyrhachis quintessence oils, 20 grams of Herba Lycopodii oil, 20 grams of cassia twig oils, 20 grams of Radix Angelicae Dahuricae oil, 15 grams of Caulis Spatholobi oil, 18 grams of Herba speranskiae tuberculatae oil, 15 grams of Radix Clematidis oil, 12 grams of Radix Tripterygii Wilfordii oil, 25 grams of Oleum Terebinthinaes; Carrier is the medicinal alcohol of concentration 95%.The wherein existing expelling wind and removing dampness of Herba speranskiae tuberculatae oil, as Compendium of Material Medica is said: Herba speranskiae tuberculatae " is controlled all rheumatalgia contractures of muscles and bones.If " cause limbs pain numbness, joint stuffiness because of wind-cold damp pathogen invasion and attack limbs meridians.Expelling wind and cold victory is wet again, and pathogenic factor goes all disease spontaneous recovery.Relaxing muscles and tendons and activating QI and blood in the collateral, control muscles and bones contracture.Promoting blood circulation and stopping pain, solution poison rash, priming penetrate meridians, blood vessels and dispel the wind, invigorate blood circulation, the feature of pain relieving.Radix Clematidis oil dispelling the wind and dampness pathogens arthritis, lumbocrural pain, numb limbs and tense tendons, icterohepatitis, bone choke down larynx, toothache etc.; Herba Lycopodii oil expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral, for anemofrigid-damp arthralgia, muscle arteries and veins contracture pain carbuncle.External is controlled osteopatia sprain and is swollen and ache.Oleum Terebinthinae has sterilization analgesic activity extremely strong to skin penetration power, is good liniment in medical industry.Cassia twig oil, Radix Angelicae Dahuricae oil, Caulis Spatholobi oil, Radix Tripterygii Wilfordii oil all have clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.Relaxing muscles and tendons and activating QI and blood in the collateral, dispelling wind and removing obstruction in the collateral, the function of dispelling-wind invigorating stomach.Natural pigment regulates product color, ensures that each batch of color and luster is consistent, this formula mechanism of action novelty, and drug effect is excellent.
The preparation method of a kind of Formica fusca JINGFUKANG oil externally-applied liniment for the treatment of cervical spondylosis of the present invention is:
By active component: it is in 95% medicinal alcohol carrier that polyrhachis quintessence oil, Herba Lycopodii oil, cassia twig oil, Radix Angelicae Dahuricae oil, Caulis Spatholobi oil, Herba speranskiae tuberculatae oil, Radix Clematidis oil, Radix Tripterygii Wilfordii oil, Oleum Terebinthinae add concentration, after mix homogeneously.
The present invention treats the Formica fusca JINGFUKANG oil externally-applied liniment of cervical spondylosis taking polyrhachis quintessence oil as main body, adopts pure natural Chinese herbal medicine quintessence oil compatibility to form.Formica fusca is a kind of tonic of gentleness, has strengthening the body resistance, kidney invigorating and YANG supporting, effect of nourish blood flourish muscle, eliminating blood stasis and smoothing collaterals, wherein especially remarkable with effect of the kidney invigorating.Improve immunologic function, regulating the aspects such as gonadal Function to have significant curative effect.The drug effects such as Formica fusca also has calmness, calms the nerves, antiinflammatory.Compatibility Herba Lycopodii oil, cassia twig oil, Radix Angelicae Dahuricae oil, Caulis Spatholobi oil, Herba speranskiae tuberculatae oil, Radix Clematidis oil, Radix Tripterygii Wilfordii oil, Oleum Terebinthinae, can infiltrate rapidly skin histology, promote blood of human body to follow also, remove muscle fatigue, relaxing muscles and tendons and activating QI and blood in the collateral, expelling wind and cold, dehumidifying detumescence, sterilization analgesic activity, " polyrhachis " of Ministry of Public Health approval exploitation confirmed through pharmacology analysis: have antiinflammatory, analgesia, hepatoprotective, relieving asthma, the pharmacological action widely such as calmness, spasmolytic.Clinical summary is thought: the ingredient that Formica fusca is rich in, can participate in the metabolic activity of body directly, strengthen or improve the function of body multiple systems, can effectively treat the health-care effects such as cervical spondylosis, effective percentage can reach more than 95%, embody the unique effects of " strengthening vital QI to eliminate pathogenic factors " and " treating different diseases with the same therapeutic principle ", really played the ideal effect of " ill cure the disease, without treating diseases and making health-care ".
Detailed description of the invention:
Embodiment 1: take 20 grams of 50 grams of polyrhachis quintessence oils, Herba Lycopodii oil, 20 grams of cassia twig oils, 20 grams of Radix Angelicae Dahuricae oil, 15 grams of Caulis Spatholobi oil, 18 grams of Herba speranskiae tuberculatae oil, 15 grams of Radix Clematidis oil, 12 grams of Radix Tripterygii Wilfordii oil, 25 grams of Oleum Terebinthinaes, add concentration be after 95% medicinal alcohol 70ml mix homogeneously the Formica fusca JINGFUKANG oil externally-applied liniment for the treatment of cervical spondylosis.
Embodiment 2: take 120 grams of 300 grams of polyrhachis quintessence oils, Herba Lycopodii oil, 120 grams of cassia twig oils, 120 grams of Radix Angelicae Dahuricae oil, 90 grams of Caulis Spatholobi oil, 100 grams of Herba speranskiae tuberculatae oil, 85 grams of Radix Clematidis oil, 70 grams of Radix Tripterygii Wilfordii oil, 120 grams of Oleum Terebinthinaes, add concentration be after 95% medicinal alcohol 450ml mix homogeneously the Formica fusca JINGFUKANG oil externally-applied liniment for the treatment of cervical spondylosis.
Claims (2)
1. treat the Formica fusca JINGFUKANG oil externally-applied liniment of cervical spondylosis for one kind, formed by active component and carrier, it is characterized in that: its raw material active ingredient compositions proportioning is as follows: 50 grams of polyrhachis quintessence oils, 20 grams of Herba Lycopodii oil, 20 grams of cassia twig oils, 20 grams of Radix Angelicae Dahuricae oil, 15 grams of Caulis Spatholobi oil, 18 grams of Herba speranskiae tuberculatae oil, 15 grams of Radix Clematidis oil, 12 grams of Radix Tripterygii Wilfordii oil, 25 grams of Oleum Terebinthinaes; Adding concentration is in 95% medicinal alcohol carrier 70mL.
2. treat the preparation method of the Formica fusca JINGFUKANG oil externally-applied liniment of cervical spondylosis according to one kind of claim 1, it is characterized in that: by active component: it is in 95% medicinal alcohol carrier 70mL that polyrhachis quintessence oil, Herba Lycopodii oil, cassia twig oil, Radix Angelicae Dahuricae oil, Caulis Spatholobi oil, Herba speranskiae tuberculatae oil, Radix Clematidis oil, Radix Tripterygii Wilfordii oil, Oleum Terebinthinae add concentration, after mix homogeneously.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310258851.1A CN103301216B (en) | 2013-06-26 | 2013-06-26 | Ant cervical spondylosis recovering oil liniment and preparation method thereof |
| HK14102056.1A HK1188742A1 (en) | 2013-06-26 | 2014-03-03 | Cervical vertebra rehabilitation oil paint by black ants and production methods |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310258851.1A CN103301216B (en) | 2013-06-26 | 2013-06-26 | Ant cervical spondylosis recovering oil liniment and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103301216A CN103301216A (en) | 2013-09-18 |
| CN103301216B true CN103301216B (en) | 2014-07-16 |
Family
ID=49127222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310258851.1A Expired - Fee Related CN103301216B (en) | 2013-06-26 | 2013-06-26 | Ant cervical spondylosis recovering oil liniment and preparation method thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN103301216B (en) |
| HK (1) | HK1188742A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115969896A (en) * | 2022-11-25 | 2023-04-18 | 韩赵成 | External analgesic |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342462A (en) * | 2000-09-08 | 2002-04-03 | 何兴峰 | Composite medicine for treating rheumatoid arthritis |
| CN1557445A (en) * | 2004-02-11 | 2004-12-29 | 潘纪修 | Chinese patent medicine for treating cervical spondylosis |
| CN1883576A (en) * | 2006-06-01 | 2006-12-27 | 刘福生 | Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion |
| CN101406655A (en) * | 2008-11-27 | 2009-04-15 | 朱利平 | Chinese medicinal composition for treating lumbar and cervical vertebra disease |
| CN101647922A (en) * | 2009-09-11 | 2010-02-17 | 陈荣华 | Pharmaceutical formulation for treating cervical hyperplasia of lumbar disc herniation and rheumatoid arthritis |
| CN102119989A (en) * | 2011-03-08 | 2011-07-13 | 孙玉芝 | Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis |
| CN102139032A (en) * | 2011-03-24 | 2011-08-03 | 王云宏 | Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease |
| CN102380050A (en) * | 2011-12-10 | 2012-03-21 | 闫位国 | Medicament for treating pain in neck, shoulders, low back and legs and preparation method thereof |
| CN102406789A (en) * | 2011-11-23 | 2012-04-11 | 王瑞莉 | Plaster for treating cervical spondylosis |
| CN102600413A (en) * | 2012-02-06 | 2012-07-25 | 杨家驥 | Fumigated Chinese herbal medicine for treating neck, shoulder, waist and leg pains and preparation method thereof |
| CN102973750A (en) * | 2012-11-21 | 2013-03-20 | 贾福敏 | Chinese traditional medicine for curing rheumatic, rheumatoid and gouty arthritis and cervical spondylosis |
-
2013
- 2013-06-26 CN CN201310258851.1A patent/CN103301216B/en not_active Expired - Fee Related
-
2014
- 2014-03-03 HK HK14102056.1A patent/HK1188742A1/en not_active IP Right Cessation
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342462A (en) * | 2000-09-08 | 2002-04-03 | 何兴峰 | Composite medicine for treating rheumatoid arthritis |
| CN1557445A (en) * | 2004-02-11 | 2004-12-29 | 潘纪修 | Chinese patent medicine for treating cervical spondylosis |
| CN1883576A (en) * | 2006-06-01 | 2006-12-27 | 刘福生 | Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion |
| CN101406655A (en) * | 2008-11-27 | 2009-04-15 | 朱利平 | Chinese medicinal composition for treating lumbar and cervical vertebra disease |
| CN101647922A (en) * | 2009-09-11 | 2010-02-17 | 陈荣华 | Pharmaceutical formulation for treating cervical hyperplasia of lumbar disc herniation and rheumatoid arthritis |
| CN102119989A (en) * | 2011-03-08 | 2011-07-13 | 孙玉芝 | Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis |
| CN102139032A (en) * | 2011-03-24 | 2011-08-03 | 王云宏 | Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease |
| CN102406789A (en) * | 2011-11-23 | 2012-04-11 | 王瑞莉 | Plaster for treating cervical spondylosis |
| CN102380050A (en) * | 2011-12-10 | 2012-03-21 | 闫位国 | Medicament for treating pain in neck, shoulders, low back and legs and preparation method thereof |
| CN102600413A (en) * | 2012-02-06 | 2012-07-25 | 杨家驥 | Fumigated Chinese herbal medicine for treating neck, shoulder, waist and leg pains and preparation method thereof |
| CN102973750A (en) * | 2012-11-21 | 2013-03-20 | 贾福敏 | Chinese traditional medicine for curing rheumatic, rheumatoid and gouty arthritis and cervical spondylosis |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1188742A1 (en) | 2014-05-16 |
| CN103301216A (en) | 2013-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103142953A (en) | Foot-bath health-protective Chinese medicament powder | |
| CN1322885C (en) | Plaster medicine composition with multiple purpose for treating affection pain due to dampness | |
| CN101919927B (en) | Spray for promoting scald healing | |
| CN103301407A (en) | Ant wind dispelling essential oil liniment and preparation method thereof | |
| CN103301216B (en) | Ant cervical spondylosis recovering oil liniment and preparation method thereof | |
| CN100512846C (en) | A medicinal tincture and method for preparing the same | |
| CN104940776A (en) | Traditional Chinese medicine composition for mud-moxibustion rheumatic diseases | |
| CN103301233B (en) | Ant essential oil liniment for treating gout disease and preparation method thereof | |
| CN109223866A (en) | A kind of wormwood powder for dipping feet and preparation method thereof | |
| CN103462833A (en) | Scouring bath Chinese herbal medicine formula and preparation method thereof | |
| CN103127473A (en) | Pain-relieving paste | |
| CN101780193A (en) | Special-effect plaster for treating fractures and various non-healing wounds | |
| CN101313959A (en) | Plaster medicament for treating scabies | |
| CN111671871A (en) | Chinese herbal medicine for treating joint diseases by Mongolian donkey bone sibutrol therapy | |
| CN109847037A (en) | A kind of medicine-filled pillow and method for cure scapulohumeral periarthritis | |
| CN103550446A (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
| CN103006945B (en) | Multifunctional medicinal liquor for external use | |
| CN107184669A (en) | External traumatic medicinal liquor and preparation method thereof | |
| CN105497266A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101804179A (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN107929636A (en) | A kind of Traditional Chinese medicinal spray for treating pain and preparation method thereof | |
| CN101204419A (en) | Tincture medicine for neurodermitis | |
| CN105169246A (en) | Medicine for treating deadlimb | |
| CN103735724A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1188742 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1188742 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140716 Termination date: 20160626 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |